Crossmark

Exciting times ahead for older patients with acute myeloid leukemia: azacitidine and venetoclax followed by allogeneic hematopoietic cell transplantation

Crossref DOI link: https://doi.org/10.1038/s41409-021-01474-9

Published Online: 2021-10-13

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bazarbachi, Ali https://orcid.org/0000-0002-7171-4997
License Information

Text and Data Mining valid from 2021-10-13

Version of Record valid from 2021-10-13
More Information

Article History

Received: 19 August 2021

Revised: 3 September 2021

Accepted: 15 September 2021

First Online: 13 October 2021

Conflict of interest

: The author declares no competing interests.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below